Company: BWAY
Filing Date: 2025-04-22
Form Type: 20-F
Source: 0001171843-25-002347
Chunk: 3

Company: Brainsway Ltd.
Filing Date: 2025-04-22
Form: 20-F
Item: Item 5
Chunk 3
---
 operators or if they use the Deep TMS inadequately, we may be unable to achieve our expected growth.  
 ──────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────

  Failure to secure or maintain adequate coverage and reimbursement of our Deep TMS system                                                         
  for the currently authorized indications and other indications for which we obtain FDA authorization in the future, if any, may make physicians  
  reluctant to use or recommend Deep TMS and have a material adverse effect on our sales, results of operations, and financial condition.          
 ───────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────

  We rely on third parties, including suppliers for some components used in manufacturing                                                   

  Clinical trials involve a lengthy and expensive process with an uncertain outcome,              
  which may delay or cause us to abandon the development of Deep TMS for additional indications.  
 ──────────────────────────────────────────────────────────────────────────────────────────────────

  Our collaboration arrangements may not be successful, which could adversely affect  
  our ability to develop and commercialize our products.                              
 ──────────────────────────────────────────────────────────────────────────────────────

   3  

  We bear the risk of product liability lawsuits and warranty claims which might harm                                                       
  our business, may not be covered by our insurance policies or may exceed our insurance policy coverage, and we may not have enough funds  
  to cover such claims or lawsuits damages.                                                                                                 
 ────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────

  Our operations could be affected in the event of further geopolitical instability,                                                      

  Our reliance on the use of technology may adversely affect our business if we become                                                      
  subject to cyber-terrorism or other compromises and shut-downs or if we experience significant disruptions in our information technology  
  systems, and security and privacy breaches may expose us to liability and harm our reputation and business.                               
 ────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────

  We may seek to grow our business through acquisitions or investments in new or complementary                                               
  businesses, products or technologies, and/or through the licensing of products or technologies from third parties. The failure to manage   
  acquisitions, investments, licenses or other strategic alliances, or the failure to integrate them with our existing business, could harm  
  our business.                                                                                                                              
 ─────────────────────────────────